Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
Expression of the beta(3) integrin subunit in melanoma in situ has been found to correlate with tumor thickness, the ability to invade and metastasize, and poor prognosis. Transition from the radial growth phase (RGP) to the vertical growth phase (VGP) is a critical step in melanoma progression and survival and is distinguished by the expression of beta(3) integrin. The molecular pathways that operate in melanoma cells associated with invasion and metastasis were examined by ectopic induction of the beta(3) integrin subunit in RGP SBcl2 and WM1552C melanoma cells, which converts these cells to a VGP phenotype. We used cDNA representational difference analysis subtractive hybridization between beta(3)-positive and -negative melanoma cells to assess gene expression profile changes accompanying RGP to VGP transition. Fourteen fragments from known genes including osteonectin (also known as SPARC and BM-40) were identified after three rounds of representational difference analysis. Induction of osteonectin was confirmed by Northern and Western blot analysis and immunohistochemistry and correlated in organotypic cultures with the beta(3)-induced progression from RGP to VGP melanoma. Expression of osteonectin was also associated with reduced adhesion to vitronectin, but not to fibronectin. Osteonectin expression was not blocked when melanoma cells were cultured with anti-alpha(v)beta(3) LM609 mAb, mitogen-activated protein kinase, or protein kinase C inhibitors, indicating that other signaling pathway(s) operate through alpha(v)beta(3) integrin during conversion from RGP to VGP.
Sturm
Richard A
RA
The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. R.Sturm@imb.uq.edu.au
Satyamoorthy
Kapaeth
K
Meier
Freidegund
F
Gardiner
Brooke B
BB
Smit
Darren J
DJ
Vaidya
Bhavesh
B
Herlyn
Meenhard
M
D015703:Antigens, CD / Q000096:biosynthesis / Q000502:physiology*; D002448:Cell Adhesion / Q000502:physiology; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D039661:Integrin beta3; D008545:Melanoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D009361:Neoplasm Invasiveness; D015676:Osteonectin / Q000096:biosynthesis* / Q000235:genetics; D010980:Platelet Membrane Glycoproteins / Q000096:biosynthesis / Q000502:physiology*; D019030:Receptors, Vitronectin / Q000096:biosynthesis / Q000502:physiology; D012867:Skin / Q000473:pathology; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D039661:Integrin beta3; D015676:Osteonectin; D010980:Platelet Membrane Glycoproteins; D019030:Receptors, Vitronectin